about
The immunopathology of giant cell arteritis: diagnostic and therapeutic implicationsThe ubiquitin-proteasome system and cardiovascular diseaseOn to the road to degradation: atherosclerosis and the proteasomeInflammation in atherosclerosis: from pathophysiology to practiceTh17 and Th1 T-cell responses in giant cell arteritis.Immune aging and rheumatoid arthritis.Vascular damage in giant cell arteritis.Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritisStimulatory interactions between human coronary smooth muscle cells and dendritic cells.The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemiaGiant cell arteritis: immune and vascular aging as disease risk factors.Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular diseasePeroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells.Telmisartan: a different angiotensin II receptor blocker protecting a different population?Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.
P2860
Q27021465-9A973DA7-A8C0-42B0-B034-51F4111DCE01Q27021582-806E38F6-1B40-4FB5-8448-77D746DA7EADQ33554513-D703B943-FE31-4FDE-9523-E1E7A5EE7167Q33709505-25584888-07F1-4B70-95B1-674B1B8124E6Q33723160-1652ED34-38B4-46BC-BB43-C62AE65F455AQ34036703-070DD65D-4F00-4709-B525-DC97EB495CF3Q34743236-A431C36B-3DA4-4AD3-9CFB-E57DEBF6C734Q35058267-962BF0E9-2E5F-450E-8EA4-C90AB94E5681Q35188689-3280C25F-72C2-4C76-8B2E-922A7D9295DAQ35332645-215541F0-C773-431C-9617-AB7F1254902CQ35617577-C89034BF-8C54-49FE-B83B-E3C32F90A9BAQ35659471-91298BF1-D596-4D5E-8C57-D7F7F19F54C5Q35945436-0EA97EA7-8F5A-4A28-8AF2-289A0896BA7FQ37690442-C08C6EA9-714B-4C9E-AD33-4E3D03B2B325Q42380775-97886339-3E7C-4333-838F-5D2EEE8A26A5Q45774051-D65667D8-B80A-44A5-A153-E1E591A1C44AQ46962775-83BEA01E-A13C-4814-A8BE-0F67D78DFBE8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T cells in arteritis and atherosclerosis.
@en
T cells in arteritis and atherosclerosis.
@nl
type
label
T cells in arteritis and atherosclerosis.
@en
T cells in arteritis and atherosclerosis.
@nl
prefLabel
T cells in arteritis and atherosclerosis.
@en
T cells in arteritis and atherosclerosis.
@nl
P2093
P2860
P1476
T cells in arteritis and atherosclerosis.
@en
P2093
Brian R Younge
Cornelia M Weyand
Jörg J Goronzy
P2860
P304
P356
10.1097/MOL.0B013E32830BFDC2
P577
2008-10-01T00:00:00Z